A detailed history of Integrity Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Integrity Advisory, LLC holds 1,677 shares of LLY stock, worth $1.31 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
1,677
Previous 1,764 4.93%
Holding current value
$1.31 Million
Previous $570,000 7.54%
% of portfolio
0.6%
Previous 0.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$321.55 - $374.67 $27,974 - $32,596
-87 Reduced 4.93%
1,677 $0
Q3 2022

Oct 17, 2022

SELL
$296.48 - $337.87 $35,281 - $40,206
-119 Reduced 6.32%
1,764 $570,000
Q2 2022

Jul 27, 2022

SELL
$278.73 - $327.27 $28,987 - $34,036
-104 Reduced 5.23%
1,883 $610,000
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $466,329 - $579,528
1,987 New
1,987 $569,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Integrity Advisory, LLC Portfolio

Follow Integrity Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrity Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrity Advisory, LLC with notifications on news.